Intest Res.  2018 Jul;16(3):494-498. 10.5217/ir.2018.16.3.494.

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial

Affiliations
  • 1The Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan. thisamatsu@ks.kyorin-u.ac.jp
  • 2Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • 3Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Japan.
  • 4Department of Gastroenterology and Hepatology, National Hospital Organization, Higashi-Ohmi Medical Center, Higashi-Ohmi, Japan.
  • 5Department of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
  • 6Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • 7Division of Gastroenterology, Osaka City General Hospital, Osaka, Japan.
  • 8Department of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Japan.
  • 9Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
  • 10Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • 11Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • 12Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
  • 13Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.
  • 14Department of Internal Medicine, Toho University Sakura Medical Centre, Sakura, Japan.
  • 15Yokoyama IBD Clinic, Aichi, Japan.
  • 16Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • 17Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
  • 18Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.

Abstract

No abstract available.


MeSH Terms

Crohn Disease*
Food, Formulated*
Humans
Infliximab*
Infliximab
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error